Introducing the new Longevity Global Community Platform! You can search for jobs, hires, investors, clients, and collaborators in the longevity space using the search function. You can view other member's bios and request warm intros. Check it out here: https://lnkd.in/g-4RCtcf Become a member here: https://lnkd.in/gZxJYpd3 Basic membership is free.
Longevity Global
生物技术研究
Non-profit connecting longevity researchers, entrepreneurs, and investors to create community and collaboration.
关于我们
Connecting longevity researchers, investors, and entrepreneurs to build community and collaboration. In person events and virtual with chapters in SF, NYC, and expanding.
- 网站
-
https://longevitygl.org/
Longevity Global的外部链接
- 所属行业
- 生物技术研究
- 规模
- 2-10 人
- 总部
- San Francisco
- 类型
- 个体经营
- 创立
- 2022
地点
Longevity Global员工
-
Veronica O'Quinn
Executive Leader, Services, Customer Success & Operations | Passionate about Digital Health Innovation
-
Justin Taylor
Product Manager at Estateworks
-
Nikola T. Markov
Neuroscientist | Bioinformatician | Longevity scientist | Biotechnologies | Project Management | PhD Neuroscience | BS Cell Biology and Physiology
-
Guilherme Tonial
Senior Health Copywriter ? Digital Strategist ? Biotechnologist
动态
-
Our portfolio company GrantTeacherAI supports SBIR grant writing. There are 500 tokens for free at signup, enough to complete 1 to 2 grant applications.? With the April 5th NIH SBIR deadlines approaching, sign up at?https://lnkd.in/gf6GV9A7?for this special offer. When Monday Mar 10, 2025 ? 5pm – 6pm (Pacific Time) Location https://lnkd.in/gVTgbb6E
-
CEO & Co-founder, NeuroAge Therapeutics | Founder & Executive Director, Longevity Global
I had a great time catching up with Matt Kaeberlein in Seattle and recording an episode on the Optispan podcast. Brain Aging & Alzheimer’s Prevention: The Future of Cognitive Health Testing | Dr. Christin Glorioso https://lnkd.in/g9Mm-CYS
Brain Aging & Alzheimer’s Prevention: The Future of Cognitive Health Testing | Dr. Christin Glorioso
https://www.youtube.com/
-
Your thought leadership thought partner | Editorial Consultant | Content Strategist | Content Writer | Ghostwriter | Bespoke marketing services for Medical Device ? Life Sciences ??Healthcare
Thank you Longevity Global for hosting a terrific networking event in Berkeley, CA on Saturday. Two wins for me: 1. It was exciting to meet people who are researching treatments and other solutions that will help people live better. More quality in their years. 2. It was gratifying to chat with people who understand the value in what I do best: translating their scientific breakthroughs so that their chosen audience will get it, and be as excited about it as they are. Until next time! #longevity #biotech #medtech
-
-
Your thought leadership thought partner | Editorial Consultant | Content Strategist | Content Writer | Ghostwriter | Bespoke marketing services for Medical Device ? Life Sciences ??Healthcare
Thank you Longevity Global for hosting a terrific networking event in Berkeley, CA on Saturday. Two wins for me: 1. It was exciting to meet people who are researching treatments and other solutions that will help people live better. More quality in their years. 2. It was gratifying to chat with people who understand the value in what I do best: translating their scientific breakthroughs so that their chosen audience will get it, and be as excited about it as they are. Until next time! #longevity #biotech #medtech
-
-
Incredible Night at the Longevity Global Event in San Diego! ???? What an amazing evening with Ronjon Nag, Christin Glorioso, MD PHD , and yours truly, expertly moderated by Julio de Unamuno IV. The longevity scene in San Diego is thriving, and the strong turnout speaks to its potential as a leading innovation hub in this space. Thrilled to bring this conversation to San Diego—and already gearing up for the next one! Stay tuned! ?? A huge thank you to HomeLab for hosting this fantastic event! ? #Longevity #BrainAging #Networking #Biotech #SanDiego
-
-
-
-
-
+1
-
-
Postdoctoral Researcher at Gladyshev Lab (Harvard Medical School - Brigham and Women's Hospital)
I feel proud that our manuscript was selected for the first Longevity Global journal club of 2025! Very happy to have been able to participate in the discussion about organ-specific aging ??
CEO & Co-founder, NeuroAge Therapeutics | Founder & Executive Director, Longevity Global
Longevity Global had a great discussion of aging clocks and the below paper at our journal club "Plasma protein-based organ-specific aging and mortality models unveil diseases as accelerated aging of organismal systems" Ludger Goeminne?? Anastasiya?Vladimirova??? Alec?Eames?? Alexander?Tyshkovskiy??? M. Austin?Argentieri?? ?Kejun?Ying??? Mahdi Moqri??? Vadim Gladyshev Read the paper: https://lnkd.in/g9DqMzJ7 We had the first author, Ludger Goeminne, there commenting, which was a real treat. Big thanks to Rebekah Brooks, PhD, Mary Boyajian, and Vishal Birar, Ph.D. for organizing and moderating Watch on YouTube ?? Join Longevity Global to come to the next one: https://longevitygl.org/. Basic membership is free.
Longevity Global Journal Club- Feb, 2025
https://www.youtube.com/
-
Our first east coast summit is live! Space is limited, register early for this one!
I am so delighted to formally announce Longevity Global's east coast summit in June, the Aging Code Summit. It's a 2-day event with a uniquely structured summit as the first day and a pitch competition as the second. It's created in partnership with Noriko Yokoi, Ph.D. and Daniel Dacey (Mindvyne) Day 1 - The first day, our AI in Longevity Summit won't just be a bunch of lectures, we've curated panels of the top visionaries in Longevity biotech and you get to watch what happens as they discuss different aspects of the rapid progress of longevity innovation, centered around the impact of AI. I've posted some of the speakers below and we're likely to have some surprise guest speakers as well. Day 2 - The second day will be a pitch competition featuring innovative startups. You will get to meet top investors and entrepreneurs in the field and hear from our finalists before a winner is selected. We expect to have really impactful prizes to give out to the winners that will help them move forward with their work. Register now (we unfortunately have very limited numbers of tickets for these events, especially the first day): agingcodesummit.com Here's a sample of some of our speakers (linkedin won't let me tag everyone): George Church Christin Glorioso, MD PHD Michael Ringel Junaid Mian, RPh Fiona Miller José Navarro Betancourt, MD, PhD Spring Behrouz Raiany Romanni, PhD Leon Peshkin Jaynee Sasso, MBA Mahdi Moqri Petrina Kamya, Ph.D. Ronjon Nag Tayo Sanders II Shane Hegarty Ali Siam
-
CEO & Co-founder, NeuroAge Therapeutics | Founder & Executive Director, Longevity Global
New study digging into who has side effects with Lilly's anti-amyloid antibody therapy for Alzheimer's and why. This could allow us to predict and avoid side effects. The worsening of side effects in people who have the genetic risk factor, APOE4, is hypothesized to be due to their greater amyloid burden. Starting therapy earlier, before they have so much amyloid accumulation, could be a good strategy for lessening side effects. There are serious side effects (brain bleeding and swelling (ARIA)) with Lilly's newly approved anti-amyloid therapy, Donanemab, in about 20% of people. There were 6 factors that predicted who had side effects. The largest risk factors were: -APOE4 carriers -high blood pressure -siderosis (the accumulation of iron deposits in the brain's surface layers) Read the study: https://lnkd.in/g8cPUbZN
Donanemab, an amyloid-targeting therapeutic,?was recently approved in July 2024. Third such therapy to be approved brought hope with evidence that stopping treatment when amyloid plaques were removed is possible. This critical article summarizing the safety issues (ARIA - amyloid associated imaging abnormalities) associated with this treatment highlights that much much more needs to be developed in this space. Namely, the analysis from TRAILBLAZER-ALZ and ALZ 2 randomized clinical trials relveal: ?? Higher ARIA Risk: Donanemab increased ARIA-E (20–24%) and ARIA-H (27–31%) cases. ?? APOE ε4 Influence: APOE ε4 carriers, especially homozygotes, faced higher ARIA risk. ?? Early Onset: Most serious ARIA events occurred within the first three infusions. ?? Modifiable Risks: Elevated blood pressure increased ARIA risk; antihypertensives reduced it. ?? Monitoring Matters: Rigorous safety monitoring is crucial during treatment. Read more here: https://lnkd.in/d5T9vEsA More research and much more funding to support these activities are needed to better understand ARIA risk factors and improve safety monitoring for patients receiving donanemab and other amyloid-targeting therapies. #AlzheimersResearch #ClinicalTrials #Neurodegeneration #innovation #funding #supportscience
-
-
I am so delighted to formally announce Longevity Global's east coast summit in June, the Aging Code Summit. It's a 2-day event with a uniquely structured summit as the first day and a pitch competition as the second. It's created in partnership with Noriko Yokoi, Ph.D. and Daniel Dacey (Mindvyne) Day 1 - The first day, our AI in Longevity Summit won't just be a bunch of lectures, we've curated panels of the top visionaries in Longevity biotech and you get to watch what happens as they discuss different aspects of the rapid progress of longevity innovation, centered around the impact of AI. I've posted some of the speakers below and we're likely to have some surprise guest speakers as well. Day 2 - The second day will be a pitch competition featuring innovative startups. You will get to meet top investors and entrepreneurs in the field and hear from our finalists before a winner is selected. We expect to have really impactful prizes to give out to the winners that will help them move forward with their work. Register now (we unfortunately have very limited numbers of tickets for these events, especially the first day): agingcodesummit.com Here's a sample of some of our speakers (linkedin won't let me tag everyone): George Church Christin Glorioso, MD PHD Michael Ringel Junaid Mian, RPh Fiona Miller José Navarro Betancourt, MD, PhD Spring Behrouz Raiany Romanni, PhD Leon Peshkin Jaynee Sasso, MBA Mahdi Moqri Petrina Kamya, Ph.D. Ronjon Nag Tayo Sanders II Shane Hegarty Ali Siam